# Planning and Evaluation

> **NIH NIH P30** · UNIV OF NORTH CAROLINA CHAPEL HILL · 2021 · $574,270

## Abstract

ABSTRACT: PLANNING AND EVALUATION
The LCCC internal and external advisory groups provided invaluable guidance in planning and evaluation of all
the major initiatives and includes:
 • The Senior Leadership Team, which is composed of the Director, Deputy Director and Associate
 Directors and meets weekly to evaluate progress in strategic LCCC initiatives.
 • The Program Planning Committee, which meets monthly to evaluate progress of all important initiatives
 and includes institutional and Research Program Leaders, as well as the Senior Leadership Team.
 • The Internal Advisory Board, comprised of institutional leaders including the Chancellor; Dean of the
 College of Arts and Sciences, Deans of the Schools of Medicine, Pharmacy, and Public Health and
 external advisors, and meets with the Director at least quarterly.
 • The Scientific Advisory Board (SAB), which is comprised of expert external advisors, and which was
 expanded with the addition of two new members in 2018/19 to provide additional expertise in specific
 areas such as community outreach and engagement and clinical trials. There are now 14 members on
 the SAB with complementary expertise in basic, clinical, translational, and population sciences and
 administration. The SAB meets at least annually at the UNC LCCC.
 • The Community Advisory Board (CAB), the 12 membered CAB meets quarterly with the Director and
 COE Leadership. The CAB is geographically, racially and ethnically representative of our catchment
 area (the state of North Carolina) and offers a variety of important perspectives and constituencies,
 including cancer survivors and caregivers, community and faith-based organizations, rural and urban
 areas, state and non-profit agencies, and under-represented minorities.
These coordinated teams of advisors provide critical advice and guidance, both annually in the fall and ad-hoc
as required, ensuring that LCCC most effectively set priorities and pursues objectives that promote basic,
clinical, prevention and translational research at the Center. With careful planning and critical input from
advisory groups, the Director initiated a new 5 year strategic planning process, reorganized operating
committees, continued significant recruitment, launched new population-based studies, strengthened
community outreach efforts, and expanded immunotherapy and GMP infrastructure.

## Key facts

- **NIH application ID:** 10089822
- **Project number:** 2P30CA016086-45
- **Recipient organization:** UNIV OF NORTH CAROLINA CHAPEL HILL
- **Principal Investigator:** H. Shelton Earp
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $574,270
- **Award type:** 2
- **Project period:** 1997-06-01 → 2025-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10089822

## Citation

> US National Institutes of Health, RePORTER application 10089822, Planning and Evaluation (2P30CA016086-45). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10089822. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*